Topiramate

Product NDC
70518-3067
11-digit product format
705183067
Labeler code
70518
Product ID
70518-3067_c3dfd903-81c4-2208-e053-2995a90a2bb5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Topiramate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA077627
Marketing category
ANDA
Marketing start
2021-04-07
Marketing end
0000-00-00
Substance
TOPIRAMATE
Active strength
200 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-3067TOPIRAMATE TABLET, FILM COATED [REMEDYREPACK INC.]5Legacy NDC20240312_86b0ef4e-aaf4-4f37-b576-bc11c3e0bf08.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3067-07051830670030 POUCH in 1 BOX (70518-3067-0) > 1 TABLET, FILM COATED in 1 POUCH (70518-3067-1) 30 pouch2021-04-070000-00-00NoNoCurrent
70518-3067-27051830670260 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3067-2) 2021-06-030000-00-00NoNoCurrent